Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771499016 | Selegiline only product in oromucosal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3771500013 | Product containing only selegiline in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selegiline only product in oromucosal dose form | Is a | Selegiline-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
| Selegiline only product in oromucosal dose form | Is a | Selegiline only product | true | Inferred relationship | Some | ||
| Selegiline only product in oromucosal dose form | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Some | ||
| Selegiline only product in oromucosal dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Selegiline only product in oromucosal dose form | Has active ingredient | Selegiline | true | Inferred relationship | Some | 1 | |
| Selegiline only product in oromucosal dose form | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Is a | False | Selegiline only product in oromucosal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR